Table 3.
Description of the Sample by Normal Tissue vs. PaC with and without Diabetesa
| Characteristic | Normal Tissue (n = 21) | PaC no DM (n = 37) | PaC-DM (n = 10) | p b |
|---|---|---|---|---|
| FABP-1 positivec | 1 (5%) | 9 (24%) | 5 (50%) | 0.02 |
| FABP-1 Score | 0.02 | |||
| 0: Negative | 20 (95%) | 28 (76%) | 5 (50%) | |
| 1: 1-25% | 0 (0%) | 7 (19%) | 3 (30%) | |
| 2: 25-75% | 1 (5%) | 2 (5%) | 1 (10%) | |
| 3: > 75% | 0 (0%) | 0 (0%) | 1 (10%) |
aTable values are n (column %). Due to missing data on diabetes status, the total number of patients in the PaC group was n = 47. PaC-DM represent samples from patients with pancreatic adenocarcinoma and diabetes. It was not possible to differentiate new-onset diabetics from chronic diabetics.
bp values represent Nonparametric Kruskal-Wallis ANOVA.
cFABP-1 positive defined as FABP-1 score ≥ 1.